Thomas A Kent Selected Research

Thomas A Kent Research Topics

Disease

23	Stroke (Strokes) 12/2021 - 02/2002
18	Ischemic Stroke 12/2021 - 01/2005
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2021 - 12/2012
5	Hyperglycemia 01/2018 - 07/2004
4	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2019 - 09/2012
4	Infarction (Infarctions) 10/2018 - 12/2012
4	Ischemia 01/2017 - 02/2002
4	Hypoxia (Hypoxemia) 10/2008 - 02/2002
3	Hypotension (Low Blood Pressure) 01/2019 - 09/2012
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2016 - 02/2002
2	Gliosis 12/2021 - 01/2017
2	Hemorrhage 01/2020 - 09/2010
2	Cerebral Hemorrhage 01/2020 - 01/2019
2	Brain Ischemia (Cerebral Ischemia) 06/2019 - 10/2018
2	Brain Injuries (Brain Injury) 01/2017 - 10/2008
2	Edema (Dropsy) 08/2014 - 01/2014
2	Thrombosis (Thrombus) 09/2010 - 01/2008
2	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 10/2008 - 05/2007
2	Cerebral Infarction 02/2008 - 07/2004
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Hemorrhagic Shock 06/2019
1	Brain Contusion 01/2019
1	Hematoma 01/2019
1	Intracranial Thrombosis (Cerebral Thrombosis) 01/2019
1	Brain Neoplasms (Brain Tumor) 10/2018
1	Glioblastoma (Glioblastoma Multiforme) 10/2018
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2018
1	Transient Ischemic Attack 01/2018
1	Neurologic Manifestations (Neurological Manifestations) 01/2017
1	Insulin Resistance 01/2016
1	Embolic Stroke 08/2014
1	Brain Edema (Cerebral Edema) 08/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014
1	Hypoglycemia (Reactive Hypoglycemia) 01/2014
1	Wounds and Injuries (Trauma) 01/2014
1	Brain Concussion (Cerebral Concussion) 05/2013
1	Thrombotic Stroke 09/2010

Drug/Important Bio-Agent (IBA)

8	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 05/2009
7	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 02/2008
6	CarbonIBA 01/2020 - 09/2012
6	Abciximab (ReoPro)FDA Link 09/2010 - 01/2005
5	AntioxidantsIBA 02/2020 - 09/2012
4	Oxygen (Dioxygen)IBA 12/2021 - 06/2004
4	Ethylene Glycol (Monoethylene Glycol)IBA 06/2019 - 09/2012
4	Heparin (Liquaemin)FDA LinkGeneric 09/2010 - 01/2005
3	Neuroprotective AgentsIBA 01/2019 - 01/2016
3	Glyburide (Glibenclamide)FDA LinkGeneric 08/2014 - 11/2012
3	Superoxides (Superoxide)IBA 12/2012 - 06/2004
2	Phosphotransferases (Kinase)IBA 12/2021 - 10/2018
2	IronIBA 01/2020 - 01/2020
2	Glial Fibrillary Acidic ProteinIBA 10/2018 - 01/2017
2	Streptozocin (Streptozotocin)FDA Link 01/2018 - 12/2012
2	GraphiteIBA 01/2016 - 05/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2012 - 10/2008
2	Platelet Membrane Glycoprotein IIbIBA 09/2010 - 01/2008
2	CytokinesIBA 05/2007 - 02/2002
1	Vascular Endothelial Growth Factor DIBA 12/2021
1	ORALIT (ORS)IBA 12/2021
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 12/2021
1	Vitamin E FDA LinkGeneric 02/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Hemin (Panhematin)FDA Link 01/2020
1	boldenone undecylenate (Equipoise)IBA 01/2019
1	Hemostatics (Antihemorrhagics)IBA 01/2019
1	necrostatin-1IBA 10/2018
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2018
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2018
1	CA 074 methyl esterIBA 01/2017
1	NeurocanIBA 01/2017
1	Cathepsin BIBA 01/2017
1	Class 5 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2017
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2017
1	Pioglitazone (Actos)FDA Link 01/2016
1	HydrogelsIBA 01/2016
1	graphene oxideIBA 01/2016
1	Biological ProductsIBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014
1	MetalsIBA 01/2014
1	Sulfonylurea ReceptorsIBA 01/2014
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2012
1	Coloring Agents (Dyes)IBA 12/2012
1	Fluorescent Dyes (Fluorescent Probes)IBA 12/2012
1	3-nitrotyrosineIBA 12/2012
1	Adenosine Triphosphate (ATP)IBA 11/2012
1	Platelet Membrane GlycoproteinsIBA 09/2010
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2008

Therapy/Procedure

14	Therapeutics 01/2020 - 07/2004
3	Resuscitation 01/2019 - 10/2008
1	Patient Transfer (Patient Dumping) 01/2019
1	Catheters 01/2019
1	Intravenous Injections 01/2019
1	Investigational Therapies (Experimental Therapy) 10/2018
1	Sutures (Suture) 01/2018
1	Thrombolytic Therapy 07/2014
1	Ambulatory Care (Outpatient Care) 04/2013
1	Organ Transplantation 09/2012